[1]
|
Skopouli, F.N. and Moutsopoulos, H.M. (1994) Autoimmune Epithelitis: Sjogren’s Syndrome. Clinical and Experi-mental Rheumatology, 12, S9-S11.
|
[2]
|
Selmi, C., Bowlus, C.L., Gershwin, M.E., et al. (2011) Primary Biliary Cirrho-sis. The Lancet, 377, 1600-1609.
https://doi.org/10.1016/S0140-6736(10)61965-4
|
[3]
|
Chalifoux, S.L., Konyn, P.G., Choi, G., et al. (2017) Extra-hepatic Manifestations of Primary Biliary Cholangitis. Gut and Liver, 11, 771-780. https://doi.org/10.5009/gnl16365
|
[4]
|
Heathcote, E.J. (2000) Management of Primary Biliary Cirrhosis. The American Association for the Study of Liver Diseases Practice Guidelines. Hepatology, 31, 1005-1013. https://doi.org/10.1053/he.2000.5984
|
[5]
|
(1980) Preliminary Criteria for the Classification of Systemic Sclerosis (Scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis & Rheumatology, 23, 581-590. https://doi.org/10.1002/art.1780230510
|
[6]
|
Vitali, C., Bombardieri, S., Jonsson, R., et al. (2002) Classification Criteria for Sjogren’s Syndrome: A Revised Version of the European Criteria Proposed by the American-European Consensus Group. Annals of Rheumatic Diseases, 61, 554-558. https://doi.org/10.1136/ard.61.6.554
|
[7]
|
Petri, M., Orbai, A.M., Alarcon, G.S., et al. (2012) Derivation and Validation of the Systemic Lupus International Collabo-rating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology, 64, 2677-2686.
https://doi.org/10.1002/art.34473
|
[8]
|
Arnett, F.C., Edworthy, S.M., Bloch, D.A., et al. (1988) The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis & Rheuma-tology, 31, 315-324.
https://doi.org/10.1002/art.1780310302
|
[9]
|
Aletaha, D., Neogi, T., Silman, A.J., et al. (2010) 2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology/European League against Rheumatism Col-laborative Initiative. Arthritis & Rheumatology, 62, 2569-2581. https://doi.org/10.1002/art.27584
|
[10]
|
Bohan, A. and Peter, J.B. (1975) Polymyositis and Dermatomyositis (First of Two Parts). The New England Journal of Medicine, 292, 344-347. https://doi.org/10.1056/NEJM197502132920706
|
[11]
|
Umehara, H., Okazaki, K., Masaki, Y., et al. (2012) Comprehensive Diagnostic Criteria for IgG4-Related Disease (IgG4-RD), 2011. Modern Rheumatology, 22, 21-30. https://doi.org/10.3109/s10165-011-0571-z
|
[12]
|
Li, Y., Nishihara, E., Hirokawa, M., et al. (2010) Distinct Clinical, Serological, and Sonographic Characteristics of Hashimoto’s Thyroiditis Based with and without IgG4-Positive Plasma Cells. The Journal of Clinical Endocrinology & Metabolism, 95, 1309-1317. https://doi.org/10.1210/jc.2009-1794
|
[13]
|
Selmi, C., Meroni, P.L. and Gershwin, M.E. (2012) Primary Biliary Cirrhosis and Sjogren’s Syndrome: Autoimmune Epithelitis. Journal of Autoimmunity, 39, 34-42. https://doi.org/10.1016/j.jaut.2011.11.005
|
[14]
|
Selmi, C. and Gershwin, M.E. (2017) Chronic Autoimmune Ep-ithelitis in Sjogren’s Syndrome and Primary Biliary Cholangitis: A Comprehensive Review. Rheumatology and Ther-apy, 4, 263-279.
https://doi.org/10.1007/s40744-017-0074-2
|
[15]
|
Tanaka, A. (2021) Current Understanding of Primary Biliary Cholangitis. Clinical and Molecular Hepatology, 27, 1-21.
https://doi.org/10.3350/cmh.2020.0028
|
[16]
|
Floreani, A., Franceschet, I., Cazzagon, N., et al. (2015) Extrahepat-ic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. Clinical Reviews in Allergy & Immunology, 48, 192-197.
https://doi.org/10.1007/s12016-014-8427-x
|
[17]
|
Gershwin, M.E., Selmi C., Worman, H.J., et al. (2005) Risk Factors and Comorbidities in Primary Biliary Cirrhosis: A Controlled Interview-Based Study of 1032 Patients. Hepa-tology, 42, 1194-1202. https://doi.org/10.1002/hep.20907
|
[18]
|
Anaya, J.M., Rojas-Villarraga, A., Mantilla, R.D., et al. (2016) Polyautoimmunity in Sjogren Syndrome. Rheumatic Disease Clinics of North America, 42, 457-472. https://doi.org/10.1016/j.rdc.2016.03.005
|
[19]
|
Mason, D.K., Harden, R.M. and Alexander, W.D. (1967) The Salivary and Thyroid Glands. A Comparative Study in Man. British Dental Journal, 122, 485-489.
|
[20]
|
Abbas, Z., Asim, M., Saeed, A., et al. (2021) The Spectrum of Autoimmune Liver Disorders, Clinical Presentation, and Autoan-tibodies in Patients from a Tertiary Care Center in Pakistan. Cureus, 13, e19789.
https://doi.org/10.7759/cureus.19789
|
[21]
|
Rain, F., Durieu, I., Mackiewitz, R., et al. (1996) Dermatopolymyositis and Primary Biliary Cirrhosis. A Rare Association. La Presse Médicale, 25, 581-582.
|
[22]
|
Pamfil, C., Candrea, E., Berki, E., et al. (2015) Primary Biliary Cirrhosis—Autoimmune Hepatitis Overlap Syndrome Associated with Derma-tomyositis, Autoimmune Thyroiditis and Antiphospholipid Syndrome. Journal of Gastrointestinal and Liver Diseases, 24, 101-104. https://doi.org/10.15403/jgld.2014.1121.cpa
|
[23]
|
Tang, N., Jiao, Y., Wang, Y., et al. (2020) Inflam-matory Demyelinating Pseudotumor with Liver Dysfunction: IgG4 Related Disease with Primary Biliary Cholangitis. The American Journal of the Medical Sciences, 360, 410-413.
https://doi.org/10.1016/j.amjms.2020.05.031
|
[24]
|
Smyk, D., Cholongitas, E., Kriese, S., et al. (2011) Primary Biliary Cirrhosis: Family Stories. Autoimmune Diseases, 2011, Article ID: 189585. https://doi.org/10.4061/2011/189585
|
[25]
|
Efe, C., Wahlin, S., Ozaslan, E., et al. (2012) Autoimmune Hepati-tis/Primary Biliary Cirrhosis Overlap Syndrome and Associated Extrahepatic Autoimmune Diseases. European Journal of Gastroenterology & Hepatology, 24, 531-534.
https://doi.org/10.1097/MEG.0b013e328350f95b
|
[26]
|
Podda, M., Selmi, C., Lleo, A., et al. (2013) The Limita-tions and Hidden Gems of the Epidemiology of Primary Biliary Cirrhosis. Journal of Autoimmunity, 46, 81-87. https://doi.org/10.1016/j.jaut.2013.06.015
|
[27]
|
Wang, L., Gershwin, M.E. and Wang, F.S. (2016) Primary Bili-ary Cholangitis in China. Current Opinion in Gastroenterology, 32, 195-203. https://doi.org/10.1097/MOG.0000000000000257
|
[28]
|
Sun, Y., Haapanen, K., Li, B., et al. (2015) Women and Primary Biliary Cirrhosis. Clinical Reviews in Allergy & Immunology, 48, 285-300. https://doi.org/10.1007/s12016-014-8449-4
|
[29]
|
Sun, Y., Zhang, W., Li, B., et al. (2015) The Coexistence of Sjogren’s Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review. Clinical Reviews in Allergy & Immu-nology, 48, 301-315.
https://doi.org/10.1007/s12016-015-8471-1
|
[30]
|
Banhuk, F.W., Pahim, B.C., Jorge, A.S., et al. (2018) Relation-ships among Antibodies against Extractable Nuclear Antigens, Antinuclear Antibodies, and Autoimmune Diseases in a Brazilian Public Hospital. Autoimmune Diseases, 2018, Article ID: 9856910. https://doi.org/10.1155/2018/9856910
|
[31]
|
Lammers, W.J., Hirschfield, G.M., Corpechot, C., et al. (2015) De-velopment and Validation of a Scoring System to Predict Outcomes of Patients with Primary Biliary Cirrhosis Re-ceiving Ursodeoxycholic Acid Therapy. Gastroenterology, 149, 1804-1812e4. https://doi.org/10.1053/j.gastro.2015.07.061
|
[32]
|
Lindor, K.D., Bowlus, C.L., Boyer, J., et al. (2019) Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatolo-gy, 69, 394-419. https://doi.org/10.1002/hep.30145
|
[33]
|
Smith, A., Baumgartner, K. and Bositis, C. (2019) Cir-rhosis: Diagnosis and Management. American Family Physician, 100, 759-770.
|
[34]
|
Prince, M.I., Chetwynd, A., Craig, W.L., et al. (2004) Asymptomatic Primary Biliary Cirrhosis: Clinical Features, Prognosis, and Symptom Pro-gression in a Large Population Based Cohort. Gut, 53, 865-870.
https://doi.org/10.1136/gut.2003.023937
|
[35]
|
Tsianos, E.V., Hoofnagle, J.H., Fox, P.C., et al. (1990) Sjogren’s Syndrome in Patients with Primary Biliary Cirrhosis. Hepatology, 11, 730-734. https://doi.org/10.1002/hep.1840110504
|
[36]
|
Uddenfeldt, P., Danielsson, A., Forssell, A., et al. (1991) Features of Sjogren’s Syndrome in Patients with Primary Biliary Cirrhosis. Journal of Internal Medicine, 230, 443-448. https://doi.org/10.1111/j.1365-2796.1991.tb00470.x
|
[37]
|
Rigamonti, C., Shand, L., Feudjo, M., et al. (2006) Clinical Features and Prognosis of Primary Biliary Cirrhosis Associated with Systemic Sclerosis. Gut, 55, 388-394. https://doi.org/10.1136/gut.2005.075002
|
[38]
|
Zhang, L.N., Shi, T.Y., Shi, X.H., et al. (2013) Early Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis of Primary Biliary Cirrhosis: Results of a 14-Year Co-hort Study. Hepatology, 58, 264-272.
https://doi.org/10.1002/hep.26322
|
[39]
|
Varin, M.M., Le Pottier, L., Youinou, P., et al. (2010) B-Cell Tolerance Breakdown in Sjogren’s Syndrome: Focus on BAFF. Autoimmunity Reviews, 9, 604-608. https://doi.org/10.1016/j.autrev.2010.05.006
|
[40]
|
Gan, Y., Zhao, X., He, J., et al. (2017) Increased Interleu-kin-17F Is Associated with Elevated Autoantibody Levels and More Clinically Relevant than Interleukin-17A in Pri-mary Sjogren’s Syndrome. Journal of Immunology Research, 2017, Article ID: 4768408. https://doi.org/10.1155/2017/4768408
|
[41]
|
Li, Y., Wang, W., Tang, L., et al. (2015) Chemokine (C-X-C Motif) Ligand 13 Promotes Intrahepatic Chemokine (C-X-C Motif) Receptor 5+ Lymphocyte Homing and Aberrant B-Cell Immune Responses in Primary Biliary Cirrhosis. Hepatology, 61, 1998-2007. https://doi.org/10.1002/hep.27725
|
[42]
|
Chung, B.K., Guevel, B.T., Reynolds, G.M., et al. (2017) Phenotyping and Auto-Antibody Production by Liver-Infiltrating B Cells in Primary Sclerosing Cholangitis and Primary Biliary Cholangitis. Journal of Autoimmunity, 77, 45-54.
https://doi.org/10.1016/j.jaut.2016.10.003
|
[43]
|
Chen, W.Q., Dai, X.N., Yu, Y., et al. (2020) Analysis of Clinical Features and Prognosis in Patients with Primary Sjogren’s Syndrome and Autoimmune Liver Disease. Journal of Pe-king University. Health Sciences, 52, 886-891.
|